Health ❯ Healthcare ❯ Neurology

Dementia

Alzheimer's Disease Risk Factors Frontotemporal Dementia Cognitive Decline Dementia Prevention Vascular Dementia Mild Cognitive Impairment Cognitive Training Alzheimer's Disease Treatments Tau Proteins

Studies Point to Wider Health Benefits From GLP-1 Drugs Beyond Weight Loss

Early signals across major organs are prompting calls for formal trials.

Severe Infections Tied to Higher Dementia Risk in Large Finnish Study

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

Exeter-Led Review Flags Shingles Vaccine, Riluzole and Viagra for Alzheimer’s Trials

Genetic Study Links Obesity and High Blood Pressure to Causal Risk of Vascular Dementia

Shingles Vaccine Linked to Lower Dementia Risk in New Analyses

Shingles Vaccine Linked to Lower Dementia Risk and Fewer Deaths in New Analysis

Shingles Vaccine Linked to Slower Dementia Progression and Lower Risk, Welsh Studies Find

IQWiG Says Leqembi Shows No Added Benefit for Early Alzheimer’s Patients

Novo Nordisk Halts Phase-3 Alzheimer’s Trial of Semaglutide After Failure to Slow Decline

Rumer Willis Shares Personal Update on Bruce Willis’ Dementia

Shingles Vaccine, Viagra and Riluzole Topped Exeter-Led List for Potential Alzheimer’s Repurposing

India Approves Donanemab for Early Alzheimer’s as Lilly Targets 2026 Launch

UCL Trial Finds Accelerated MRI Cuts Dementia Scan Time by 63% Without Sacrificing Accuracy

First Patients in Germany Receive Lecanemab for Early Alzheimer’s

Australia Registers Alzheimer’s Drug Leqembi With APOE4-Based Restrictions

World Alzheimer’s Day Puts Caregivers, Prevention and New Science in Focus

Wendy Williams Returns to NYFW With Rare Back-to-Back Appearances

Emma Heming Defends Moving Bruce Willis to Nearby 24/7 Care Home

France Blocks Early Access to Alzheimer’s Drug Leqembi for Now